Setmelanotide is an 8-amino acid cyclic peptide analog of -MSH that promotes weight loss by activating MC4R to reduce hunger, thereby decreasing caloric intake and increasing energy expenditure [50]
including semaglutide branded as Wegovy or Ozempic, and tirzepatide (dual GIP/GLP-1 receptor agonist) branded as Zepbound or Mounjaro, for the management of obesity, type 2 diabetes, and other metabolic conditions increases, so too does the need to assess the advantages and potential downsides of long-term use
Rare but serious risks include pancreatitis (requiring immediate medical attention if severe abdominal pain occurs), gallbladder disease, and potential thyroid C-cell tumors (based on rodent studies)
Initiation of GLP-1 receptor agonists in post-bariatric patients follows similar protocols to other populations, with gradual dose escalation to minimise gastrointestinal side effects
With a dedicated, knowledgeable, and supportive staff, we help guide you every step of the way
The pharmacy is not located within the U.S